Your browser doesn't support javascript.
loading
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize.
Adams, Stephen R; Yang, Howard C; Savariar, Elamprakash N; Aguilera, Joe; Crisp, Jessica L; Jones, Karra A; Whitney, Michael A; Lippman, Scott M; Cohen, Ezra E W; Tsien, Roger Y; Advani, Sunil J.
Afiliação
  • Adams SR; Department of Pharmacology, University of California San Diego, La Jolla, California 92093, USA.
  • Yang HC; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California 92093, USA.
  • Savariar EN; Department of Pharmacology, University of California San Diego, La Jolla, California 92093, USA.
  • Aguilera J; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California 92093, USA.
  • Crisp JL; Department of Pharmacology, University of California San Diego, La Jolla, California 92093, USA.
  • Jones KA; Department of Pathology, University of California San Diego, La Jolla, California 92093, USA.
  • Whitney MA; Department of Pharmacology, University of California San Diego, La Jolla, California 92093, USA.
  • Lippman SM; Department of Medicine, University of California San Diego, La Jolla, California 92093, USA.
  • Cohen EE; UC San Diego, Moores Cancer Center, La Jolla, California 92093, USA.
  • Tsien RY; Department of Medicine, University of California San Diego, La Jolla, California 92093, USA.
  • Advani SJ; UC San Diego, Moores Cancer Center, La Jolla, California 92093, USA.
Nat Commun ; 7: 13019, 2016 10 04.
Article em En | MEDLINE | ID: mdl-27698471
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Resistencia a Medicamentos Antineoplásicos / Moduladores de Tubulina / Trastuzumab / Maitansina / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Resistencia a Medicamentos Antineoplásicos / Moduladores de Tubulina / Trastuzumab / Maitansina / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article